货号:A129741
同义名:
Nitrofural; Furacilin
Nitrofurazone 是一种硝基呋喃类抗菌化合物,对革兰阳性菌、革兰阴性菌及锥虫均具有抑制作用,常用于局部感染及寄生虫病研究。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Nitrofurazone, a nitroaromatic drug, is a broad spectrum antibiotic which has until now been considered as activated in bacteria by nitroreductases. Nitrofurazone-coated urinary catheter segments inhibited 51 (75%) of 70 urinary bacterial isolates from patients with indwelling catheters. All strains except the Pseudomonas spp. were inhibited by < or = 64 mg of nitrofurazone per mL[3]. On administration to rats at a subtoxic dose, the antibiotic nitrofurazone (NF) has been shown to increase hepatocyte DNA synthesis and liver weight in a dose-dependent manner, with no histological or biochemical evidence of cell damage or necrosis[4]. |
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT02099240 | Osteomyelitis | Early Phase 1 | Recruiting | September 2019 | United States, Kentucky ... 展开 >> University of Louisville Recruiting Louisville, Kentucky, United States, 40202 Contact: Julio A Ramirez, MD 502-852-1148 jarami01@louisville.edu Contact: David Seligson, MD 502-852-0923 d0seli01@louisville.edu Sub-Investigator: Forest Arnold, DO Sub-Investigator: Timothy Wiemkwn, PhD Sub-Investigator: Robert Kelley, PhD Sub-Investigator: James Summersgill, PhD Sub-Investigator: Ruth Carrico, PhD Sub-Investigator: Julie Harting, PharmD Sub-Investigator: Paula Peyrani, MD Principal Investigator: David Seligson, MD Sub-Investigator: Craig Roberts, MD Principal Investigator: Julio Ramirez, MD 收起 << |
| NCT00669747 | Ductal Carcinoma In Situ | Phase 2 | Unknown | December 2009 | United States, Oklahoma ... 展开 >> OU Medical Center Laboratory Recruiting Oklahoma City, Oklahoma, United States, 73104 Contact: William C Dooley, M.D., F.A.C.S. 405-206-5670 William-Dooley@ouhsc.edu Contact: Linda White, R.N. (949) 300-9576 lwhite@whmed.com United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Henry Kuerer, M.D. 713-745-5043 lboehnke@mdanderson.org Contact: Linda White, R.N. 949 300-9576 lwhite@whmed.com 收起 << |
| NCT00192985 | Trauma Urinar... 展开 >>y Tract Infections 收起 << | Phase 3 | Unknown | - | Denmark ... 展开 >> Rigshospitalet, Copenhagen University Hospital Copenhagen, Denmark, DK-2100 收起 << |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
5.05mL 1.01mL 0.50mL |
25.23mL 5.05mL 2.52mL |
50.47mL 10.09mL 5.05mL |
|
| CAS号 | 59-87-0 |
| 分子式 | C6H6N4O4 |
| 分子量 | 198.14 |
| SMILES Code | O=[N+](C1=CC=C(C=NNC(N)=O)O1)[O-] |
| MDL No. | MFCD00003225 |
| 别名 | Nitrofural; Furacilin; Dermofural; NSC 44009; NSC 2100; NSC 1602 |
| 运输 | 蓝冰 |
| InChI Key | IAIWVQXQOWNYOU-FPYGCLRLSA-N |
| Pubchem ID | 5447130 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 150 mg/mL(757.04 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1